Cargando…
Therapeutic potential of TNFα inhibitors in chronic inflammatory disorders: Past and future
In the past 20 years, patients with rheumatoid arthritis (RA), Crohn's disease (CD), and other immune diseases have witnessed the impact of a great treatment advance with the availability of biological TNFα inhibitors. With 5 approved anti-TNFα biologics on the market and soon available biosimi...
Autores principales: | Zhang, Hongtao, Shi, Nelson, Diao, Zhuo, Chen, Youhai, Zhang, Yejia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Chongqing Medical University
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7859422/ https://www.ncbi.nlm.nih.gov/pubmed/33569512 http://dx.doi.org/10.1016/j.gendis.2020.02.004 |
Ejemplares similares
-
PKCζ as a promising therapeutic target for TNFα-induced inflammatory disorders in chronic cutaneous wounds
por: Zhang, Jian, et al.
Publicado: (2017) -
Immune-mediated inflammatory disease therapeutics: past, present and future
por: McInnes, Iain B., et al.
Publicado: (2021) -
The Role of Tumor Necrosis Factor Alpha (TNF-α) in Autoimmune Disease and Current TNF-α Inhibitors in Therapeutics
por: Jang, Dan-in, et al.
Publicado: (2021) -
TNFAIP8 family gene expressions in the mouse tail intervertebral disc injury model
por: Tian, Zuozhen, et al.
Publicado: (2020) -
TNF-α inhibitors: are they carcinogenic?
por: Raval, Girindra, et al.
Publicado: (2010)